(Q40397259)

English

ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma.

scientific article published on August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

Shunsuke Kagawa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Fuminori Teraishi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Takanori Watanabe

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yasuhisa Tango

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Takeshi Kawashima

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Tatsuo Umeoka

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Masahiko Nisizaki

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Noriaki Tanaka

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Toshiyoshi Fujiwara

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

579

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4069-4075

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16023108%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Esophageal carcinoma: current controversies

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Phase I studies of ZD1839 in patients with common solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Ectopic p21sdi1 gene transfer induces retinoic acid receptor beta expression and sensitizes human cancer cells to retinoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.031

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40397259&oldid=1507526736"